Shi-Yong Sun

mTOR kinase inhibitors as potential cancer therapeutic drugs.

Shi-Yong Sun, Shi-Yong Sun, 2013, Cancer letters.

Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells

Mourad Tighiouart, Lily Yang, Lily Yang, 2011, Molecular Cancer Therapeutics.

The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.

Jing Chen, Fadlo R Khuri, F. Khuri, 2005, Blood.

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Li Mao, Weiguo Wu, Ignacio I Wistuba, 2004, Molecular cancer research : MCR.

p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.

Zhuo Georgia Chen, Taro Hitosugi, Wei Zhou, 2010, The Journal of clinical investigation.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.

Xiaoguang Chen, H. Ding, Shi-Yong Sun, 2015, Chemistry & biology.